[PubMed] Kamdi, S
Note: Use this product for research only
High-dose IV vitamin C can achieve blood levels impossible with oral supplements, leading to better skin elasticity and immune function
With this in mind is very important to remove all sources of processed foods, all sources containing industrial seed oils, and to eat a whole food diet
For instance, In July 2024, the MHRA approved Semaglutide, a GLP-1 receptor agonist, to reduce the risk of major cardiovascular events in obese or overweight people, underscoring its expanding benefits beyond glycemic control In December 2023, Eli Lilly and Company launched Zepbound (tirzepatide), the first dual GIP/GLP-1 receptor agonist for chronic weight management in adults with obesity or other weight-related medical problems such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease Together, such developments are reshaping the role of GLP-1 analogues from single-purpose treatments to comprehensive metabolic health solutions